Search Results

There are 21078 results for: content related to: Individual manifestations of Parkinson's disease after ten or more years of levodopa

  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Article first published online : 19 JUN 2012, DOI: 10.1002/mds.25051

  2. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Article first published online : 6 JUN 2014, DOI: 10.1002/mds.25914

  3. You have free access to this content
    Abstracts of The Movement Disorder Society's Eleventh International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 22, Issue S16, 2007, Pages: S1–S325,

    Article first published online : 24 APR 2007, DOI: 10.1002/mds.21535

  4. Levodopa

    Movement Disorders

    Volume 17, Issue S4, July/August 2002, Pages: S23–S37,

    Article first published online : 29 JUL 2002, DOI: 10.1002/mds.5558

  5. Poster session 2, Abstracts 345–694

    Movement Disorders

    Volume 19, Issue S9, 2004, Pages: S129–S244,

    Article first published online : 10 MAY 2004, DOI: 10.1002/mds.20176

  6. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Article first published online : 28 MAY 2008, DOI: 10.1002/mds.22133

  7. Dyskinesia Induced by Levodopa and Dopamine Agonists in Patients with Parkinson's Disease

    Drug Induced Movement Disorders, Second Edition

    John G. Nutt, Matthew A. Brodsky, Pages: 313–350, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753217.ch13

  8. Ascorbic acid protects against levodopa-induced neurotoxicity on a catecholamine-rich human neuroblastoma cell line

    Movement Disorders

    Volume 8, Issue 3, 1993, Pages: 278–284, Beatriz Pardo, María Angeles Mena, Stanley Fahn and Justo García de Yébenes

    Article first published online : 12 OCT 2004, DOI: 10.1002/mds.870080305

  9. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications

    Intervention Review

    The Cochrane Library

    Rebecca Stowe, Natalie Ives, Carl E Clarke, Katherine Deane, van Hilten, Keith Wheatley, Richard Gray, Kelly Handley and Alex Furmston

    Published Online : 7 JUL 2010, DOI: 10.1002/14651858.CD007166.pub2

  10. You have full text access to this OnlineOpen article
    Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets

    British Journal of Clinical Pharmacology

    Volume 78, Issue 1, July 2014, Pages: 94–105, Ahmed A. Othman and Sandeep Dutta

    Article first published online : 20 JUN 2014, DOI: 10.1111/bcp.12324

  11. Poster Session 2

    Movement Disorders

    Volume 21, Issue S15, September 2006, Pages: S425–S516,

    Article first published online : 20 SEP 2006, DOI: 10.1002/mds.21247

  12. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S2–S41, Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Article first published online : 21 OCT 2011, DOI: 10.1002/mds.23829

  13. Catechol-O-methyltransferase inhibitors: Clinical potential in the treatment of Parkinson's disease

    Drug Development Research

    Volume 42, Issue 1, September 1997, Pages: 1–25, Jasper Dingemanse

    Article first published online : 6 DEC 1998, DOI: 10.1002/(SICI)1098-2299(199709)42:1<1::AID-DDR1>3.0.CO;2-I

  14. Levodopa for the treatment of restless legs syndrome

    Intervention Review

    The Cochrane Library

    Hanna Scholz, Claudia Trenkwalder, Ralf Kohnen, Levente Kriston, Dieter Riemann and Magdolna Hornyak

    Published Online : 15 FEB 2011, DOI: 10.1002/14651858.CD005504.pub2

  15. Neurotoxicity of levodopa on catecholamine-rich neurons

    Movement Disorders

    Volume 7, Issue 1, 1992, Pages: 23–31, María Angeles Mena, Beatriz Pardo, María José Casarejos, Stanley Fahn and Justo García de Yébenes

    Article first published online : 12 OCT 2004, DOI: 10.1002/mds.870070105

  16. The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa

    Movement Disorders

    Volume 15, Issue 5, September 2000, Pages: 862–868, I. Reuter, S. Harder, M. Engelhardt and H. Baas

    Article first published online : 23 JAN 2001, DOI: 10.1002/1531-8257(200009)15:5<862::AID-MDS1015>3.0.CO;2-S

  17. You have free access to this content
    Pharmacokinetics of levodopa/benserazide versus levodopa/carbidopa in healthy subjects and patients with Parkinson's disease

    Neurology and Clinical Neuroscience

    Hirotaka Iwaki, Noriko Nishikawa, Masahiro Nagai, Tomoaki Tsujii, Hayato Yabe, Madoka Kubo, Ichiro Ieiri and Masahiro Nomoto

    Article first published online : 8 DEC 2014, DOI: 10.1111/ncn3.152

  18. Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight

    European Journal of Neurology

    Volume 15, Issue 5, May 2008, Pages: 493–496, J. C. Sharma, I.N. Ross, O. Rascol and D. Brooks

    Article first published online : 18 MAR 2008, DOI: 10.1111/j.1468-1331.2008.02106.x

  19. Lack of Pharmacokinetic Interactions Between Transdermal Rotigotine and Oral Levodopa/Carbidopa

    The Journal of Clinical Pharmacology

    Volume 49, Issue 9, September 2009, Pages: 1047–1055, Marina Braun, Willi Cawello, Jens-Otto Andreas, Dipl Math, Hilmar Boekens and Rolf Horstmann

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270009338481

  20. Pharmacokinetics of Levodopa/Carbidopa Delivered From Gastric-Retentive Extended-Release Formulations in Patients With Parkinson's Disease

    The Journal of Clinical Pharmacology

    Volume 52, Issue 7, July 2012, Pages: 1069–1077, Cuiping Chen, Verne E. Cowles, Mike Sweeney, Igor D. Stolyarov and Sergey N. Illarioshkin

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270011409232